Molecular Cytogenetics Market Report 2026

Molecular Cytogenetics Market Overview

• Molecular Cytogenetics market size has reached to $3.1 billion in 2025 • Expected to grow to $5.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.6% • Growth Driver: The Rise in Genetic Disorders and Cancer Fueling the Growth of the Market Due to Increasing Chromosomal Abnormalities and Diagnostic Demand • Market Trend: Revolutionizing Single-Cell RNA Sequencing, Luthor High-Definition Single Cell 3' mRNA-Seq Kit • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Molecular Cytogenetics Market?

Molecular cytogenetics refers to a set of techniques that operate with the entire genome or with specific targeted DNA sequences. It includes the structural and functional organization of the chromosome and nucleus, genome variation, expression, evolution, chromosome abnormalities, and genomic variations in the context of medical genetics and tumor genetics. The main products of the molecular cytogenetics market are instruments, kits and reagents, software, services, and consumables or accessories. Software refers to a set of instructions, data or programs used to operate computers and execute specific tasks. The technologies are comparative genomic hybridization, fluorescence in situ hybridization, immunohistochemistry, karyotyping, and other technologies. The various applications involved are genetic disorders, cancer, personalized medicines, and others. The various end-users included clinical and research laboratories, academic research institutes, pharmaceutical, biotechnology companies, and others.

What Is The Molecular Cytogenetics Market Growth Forecast?

The molecular cytogenetics market size is expected to see rapid growth in the next few years. It will grow to $5.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine approaches, rising investments in genomic research, expansion of precision oncology diagnostics, growing demand for integrated cytogenetic workflows, continuous advancements in imaging and molecular analysis technologies. Major trends in the forecast period include increasing adoption of fish and cgh technologies, rising use of genomic profiling in oncology, growing integration of automated cytogenetic platforms, expansion of bioinformatics-driven data interpretation, enhanced focus on high-throughput cytogenetic analysis.

Global Molecular Cytogenetics Market Segmentation

1) By Product: Instruments, Kits And Reagents, Software, Services 2) By Technology: Comparative Genomic Hybridization, Fluorescence In Situ Hybridization, Karyotyping, Other Technologies 3) By Application: Genetic Disorders, Cancer, Personalized Medicines, Other Applications 4) By End-User: Clinical And Research Laboratories, Academic Research Institutes, Pharmaceutical, Biotechnology Companies, Other End-Users Subsegments: 1) By Instruments: Fluorescence In Situ Hybridization (FISH) Systems, Microarray Platforms, Imaging Systems 2) By Kits And Reagents: DNA Extraction Kits, Hybridization Kits, Staining Kits 3) By Software: Data Analysis Software, Image Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Reporting Software 4) By Services: Custom Research Services, Technical Support Services, Consulting Services, Training Services, Quality Control Services

What Is The Driver Of The Molecular Cytogenetics Market?

The rising incidence of genetic disorders and cancer is expected to propel the growth of the molecular cytogenetics market going forward. Cancer occurs when abnormal cells multiply uncontrollably and spread to surrounding or distant parts of the body. The increasing burden of these conditions is driven by a combination of genetic predisposition, environmental factors, and age-related risks, resulting in a higher number of patients requiring diagnostic evaluation. Molecular cytogenetics supports clinical decision-making by enabling high-precision detection of chromosomal abnormalities, such as missing, broken, or rearranged chromosomes, that help identify congenital disorders, genetic diseases, and multiple cancer types. For instance, in July 2025, according to the National Blood Authority, an Australia-based blood management agency, there were 2,788 patients living with hereditary haemophilia A (HMA) in 2023–2024, up from 2,681 patients in 2022–2023. Therefore, the rising incidence of genetic disorders and cancer is driving the growth of the molecular cytogenetics industry.

Key Players In The Global Molecular Cytogenetics Market

Major companies operating in the molecular cytogenetics market are Abbott Laboratories, Agilent Technologies Inc, Applied Spectral Imaging, CytoTest Inc, Danaher Corporation, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Oxford Gene Technology Limited, Affymetrix Inc, F. Hoffmann-La Roche AG, Cytognomix Inc, Empire Genomics LLC, Genial Genetic Solutions Ltd., BioChain Institute Inc, BioGenex Laboratories Inc, Bio-Techne Corporation, Cytocell Ltd., Kreatech Diagnostics B.V., Leica Biosystems Nussloch GmbH, MetaSystems Group Holding GmbH, SciGene Corporation, SkylineDx B.V., Roche Diagnostics Corporation

Global Molecular Cytogenetics Market Trends and Insights

Major companies operating in the molecular cytogenetics market are developing innovative products, such as LUTHOR High-Definition Single Cell 3' mRNA-Seq Kit, to meet the growing demand and capitalize on the expanding market opportunities. This kit revolutionizes single-cell RNA sequencing by offering an RNA-amplification-based approach that can detect virtually every single mRNA molecule present in the cell. For instance, in November 2023, Lexogen GmbH, an Austria-based biotechnology company, launched LUTHOR High-Definition Single Cell 3' mRNA-Seq Kit. This kit is a cutting-edge protocol that sets new standards in single-cell RNA sequencing, enabling the detection of even a single gene copy within a cell and capturing 95% of expressed genes at a 1 million read depth. The key to LUTHOR HD’s exceptional sensitivity lies in its innovative THOR (T7 High-resolution Original RNA amplification) technology, which amplifies RNA directly from the original mRNA, overcoming the limitations of low-copy transcripts.

What Are Latest Mergers And Acquisitions In The Molecular Cytogenetics Market?

In May 2024, Bruker Corporation, a US-based scientific instruments company, acquired NanoString Technologies Inc. for an undisclosed amount. Through this acquisition, Bruker aims to enhance its molecular analysis capabilities by integrating NanoString’s gene expression and spatial biology platforms, including nCounter, GeoMx, CosMx, and AtoMx, into its discovery and translational research portfolio. NanoString Technologies Inc. is a US-based life science tools company known for its high-plex gene expression and spatial transcriptomics instruments.

Regional Outlook

North America was the largest region in the molecular cytogenetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global molecular cytogenetics market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Molecular Cytogenetics Market?

The molecular cytogenetics market consists of revenues earned by entities by providing in situ hybridization, and banding techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. The molecular cytogenetics market also includes sales of diagnostic tools, and instrumentation which are used for providing molecular cytogenetics services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.